Docket Number:13A-1011121
Inventor:Che-Kun James Shen, Chang-Chung Chen
IP Status:Issued TW patent I 545322, PCT pending
Abstract:
We have discovered that the mouse and/or human DNMT1, DNMT3A, and DNMT3B all could act as active DNA demethylase. These newly discovered DNMTs should be an equally important factor, in parallel to their DNA methylation activities, to consider during the design/identification of reagents (including modified forms of the DNMTs or their equivalents) and straegies for modulation of different cellular activities and properties, including the manipulation of gene expression and cell fates, treatment of cancer, regulation of the neuronal activities, etc.
Fields of Application:
Biopharmaceutical drugs, Targets (DNMT1, DNMT3A, and DNMT3B) for designing/identifying reagents to treat cancers and to regulate neuronal activities.
Contact Person: 886-2-2787-2550 / cephaso@gate.sinica.edu.tw
